首页> 外文期刊>Autoimmunity >Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease.
【24h】

Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease.

机译:HLA II类的多态性使患有1型糖尿病的儿童和青少年容易患上自身免疫性甲状腺疾病。

获取原文
获取原文并翻译 | 示例
           

摘要

To determine the prevalence of autoimmune thyroid disease (AITD) in children and adolescents with type 1 diabetes mellitus (DM), and assess whether the development of AITD is correlated with specific DQ-A and DQ-B loci of the HLA class II antigens, we analyzed thyroid function using anti-thyroid antibodies and HLA-DQ-A and -DQ-B polymorphisms in 69 patients with type 1 DM, in 75 normal healthy controls, and in 21 patients with AITD but without type 1 DM. Eighteen patients (26%) in the diabetic patients had AITD. In the diabetic patients, DQA1*0301 and DQB1*0302 occurred more frequently than in controls [DQA1*0301: OR = 1.939, 95% CI = 1.210-3.109 (P = 0.008, P(c) (corrected P) < 0.05); DQB1*0302: OR = 2.558, 95% CI = 1.354-4.832 (P = 0.005, P(c), > 0.05)]. Compared with controls, non-diabetic subjects with AITD showed higher frequency of DQA1*0301 (P(c), < 0.05) and DQB1*0601 (P(c) > 0.05), but these alleles were not contributing factors in the development of AITD in diabetic patients. In diabetic patients, DQB1*0201, known as susceptible allele of type 1 DM was not a contributing factor in the development of AITD in diabetic patients. Unlike DQB1*0201, DQB1*0401 was more frequently found in diabetic patients with AITD than in controls [OR = 4.053, 95% CI = 1.607-10.221 (P = 0.0017, P(c) < 0.05)] or than in non-diabetic AITD patients [OR = 15.769, 95% CI = 1.905-130.530(P = 0.002, P(c) < 0.05)]. In non-diabetic subjects, DQB1*0401 did not provide susceptibility for AITD. Our results suggest that HLA DQB1*0401 is a predisposing genetic marker for the development of AITD in patients with type 1 DM in Korea.
机译:为了确定患有1型糖尿病(DM)的儿童和青少年自身免疫性甲状腺疾病(AITD)的患病率,并评估AITD的发展是否与HLA II类抗原的特定DQ-A和DQ-B基因座相关,我们使用抗甲状腺抗体以及HLA-DQ-A和-DQ-B多态性分析了69例1型DM患者,75名正常健康对照者和21例AITD但无1型DM患者的甲状腺功能。糖尿病患者中有18名患者(26%)患有AITD。在糖尿病患者中,DQA1 * 0301和DQB1 * 0302的发生率高于对照组[DQA1 * 0301:OR = 1.939,95%CI = 1.210-3.109(P = 0.008,P(c)(校正后的P)<0.05) ; DQB1 * 0302:OR = 2.558,95%CI = 1.354-4.832(P = 0.005,P(c),> 0.05)]。与对照组相比,患有AITD的非糖尿病受试者表现出较高的DQA1 * 0301(P(c),<0.05)和DQB1 * 0601(P(c)> 0.05)频率,但这些等位基因不是促成糖尿病发生的因素。糖尿病患者的AITD。在糖尿病患者中,DQB1 * 0201(称为1型DM易感等位基因)不是糖尿病患者AITD发生的因素。与DQB1 * 0201不同,在患有AITD的糖尿病患者中发现DQB1 * 0401的频率要高于对照组[OR = 4.053,95%CI = 1.607-10.221(P = 0.0017,P(c)<0.05)]或非DQB1 * 0401糖尿病AITD患者[OR = 15.769,95%CI = 1.905-130.530(P = 0.002,P(c)<0.05)]。在非糖尿病受试者中,DQB1 * 0401不提供AITD的易感性。我们的结果表明,HLA DQB1 * 0401是韩国1型DM患者AITD发生的易感基因标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号